Erratum: Global, regional, and national cancer incidence, mortality, years of life lost, years lived with disability, and disability-adjusted life-years for 32 cancer groups, 1990 to 2015: A systematic analysis for the global burden of disease study (JAMA Oncology (2016) DOI: 10.1001/jamaoncol.2016.5688);Global, regional, and national cancer incidence, mortality, years of life lost, years lived with disability, and disability-adjusted life-years for 32 cancer groups, 1990 to 2015: A Systematic Analysis for the Global Burden of Disease Study Global Burden of Disease Cancer Collaboration

JAMA Oncology

Volumn 3, Issue 4, 2017, Pages 524-548

  Fitzmaurice, Christina ^a,b   Allen, Christine ^b   Barber, Ryan M ^b   Barregard, Lars ^c   Bhutta, Zulfiqar A ^d   Brenner, Hermann ^e   Dicker, Daniel J ^b   Chimed Orchir, Odgerel ^f   Dandona, Rakhi ^g   Dandona, Lalit ^b   Fleming, Tom ^b   Forouzanfar, Mohammad H ^b   Hancock, Jamie ^b   Hay, Roderick J ^h   Hunter Merrill, Rachel ^b   Huynh, Chantal ^b   Hosgood, H Dean ⁱ   Johnson, Catherine O ^b   Jonas, Jost B ^j   Khubchandani, Jagdish ^k   Kumar, G Anil ^g   Kutz, Michael ^b   Lan, Qing ^l   Larson, Heidi J ^m   Liang, Xiaofeng ⁿ   Lim, Stephen S ^b   Lopez, Alan D ^o   MacIntyre, Michael F ^b   Marczak, Laurie ^b   Marquez, Neal ^b   Mokdad, Ali H ^b   Pinho, Christine ^b   Pourmalek, Farshad ^p   Salomon, Joshua A ^q   Sanabria, Juan Ramon ^r   Sandar, Logan ^b   Sartorius, Benn ^s   Schwartz, Stephen M ^t   Shackelford, Katya A ^b   Shibuya, Kenji ^u   Stanaway, Jeff ^b   Steiner, Caitlyn ^b   Sun, Jiandong ^v   Takahashi, Ken ^f   Vollset, Stein Emil ^w   Vos, Theo ^b   Wagner, Joseph A ^b   Wang, Haidong ^b   Westerman, Ronny ^x   Zeeb, Hajo ^y   Zoeckler, Leo ^b   Abd Allah, Foad ^z   Ahmed, Muktar Beshir ^aa   Alabed, Samer ^ab   Alam, Noore K ^ac   Aldhahri, Saleh Fahed ^ad   Alem, Girma ^ae   Alemayohu, Mulubirhan Assefa ^af   Ali, Raghib ^ag   Al Raddadi, Rajaa ^ah   Amare, Azmeraw ^ai,aj   Amoako, Yaw ^ak   Artaman, Al ^al   Asayesh, Hamid ^am   Atnafu, Niguse ^an   Awasthi, Ashish ^ao   Saleem, Huda Ba ^ap   Barac, Aleksandra ^aq   Bedi, Neeraj ^ar   Bensenor, Isabela ^as   Berhane, Adugnaw ^at   Bernabé, Eduardo ^au   Betsu, Balem ^af   Binagwaho, Agnes ^av,aw   Boneya, Dube ^ae   Campos Nonato, Ismael ^ax   Castañeda Orjuela, Carlos ^ay   Catalá López, Ferrán ^az,ba   Chiang, Peggy ^bb   Chibueze, Chioma ^bc   Chitheer, Abdulaal ^bd   Choi, Jee Young ^be   Cowie, Benjamin ^bf   Damtew, Solomon ^bg   Das Neves, José ^bh   Dey, Suhojit ^g   Dharmaratne, Samath ^bi   Dhillon, Preet ^g   Ding, Eric ^q   Driscoll, Tim ^bj   Ekwueme, Donatus ^bk   Endries, Aman Yesuf ^bl   Farvid, Maryam ^bm,bn   Farzadfar, Farshad ^bo   Fernandes, Joao ^bp   Fischer, Florian ^bq   Ghiwot, Tsegaye Tewelde ^aa   Gebru, Alemseged ^af   Gopalani, Sameer ^br   Hailu, Alemayehu ^bs   Horino, Masako ^bt   Horita, Nobuyuki ^bu   Husseini, Abdullatif ^bv   Huybrechts, Inge ^bw   Inoue, Manami ^u   Islami, Farhad ^bx   Jakovljevic, Mihajlo ^by   James, Spencer ^bz   Javanbakht, Mehdi ^ca   Jee, Sun Ha ^cb   Kasaeian, Amir ^cc   Kedir, Muktar Sano ^an   Khader, Yousef S ^cd   Khang, Young Ho ^ce,cf   Kim, Daniel ^cg   Leigh, James ^ch   Linn, Shai ^ci   Lunevicius, Raimundas ^cj   El Razek, Hassan Magdy Abd ^ck   Malekzadeh, Reza ^cl   Malta, Deborah Carvalho ^cm   Marcenes, Wagner ^au   Markos, Desalegn ^cn   Melaku, Yohannes A ^af   Meles, Kidanu G ^af   Mendoza, Walter ^co   Mengiste, Desalegn Tadese ^af   Meretoja, Tuomo J ^cp   Miller, Ted R ^cq,cr   Mohammad, Karzan Abdulmuhsin ^cs,ct   Mohammadi, Alireza ^cu   Mohammed, Shafiu ^cv   Moradi Lakeh, Maziar ^cw   Nagel, Gabriele ^cx   Nand, Devina ^cy   Le Nguyen, Quyen ^cz   Nolte, Sandra ^da   Ogbo, Felix A ^db   Oladimeji, Kelechi E ^s   Oren, Eyal ^dc   Pa, Mahesh ^dd   Park, Eun Kee ^de   Pereira, David M ^df   Plass, Dietrich ^dg   Qorbani, Mostafa ^dh   Radfar, Amir ^di   Rafay, Anwar ^dj   Rahman, Mahfuzar ^dk   Rana, Saleem M ^dl   Søreide, Kjetil ^dm,dn   Satpathy, Maheswar ^do   Sawhney, Monika ^dp   Sepanlou, Sadaf G ^dq   Shaikh, Masood Ali ^dr   She, Jun ^ds   Shiue, Ivy ^dt   Shore, Hirbo Roba ^du   Shrime, Mark G ^aw   So, Samuel ^dv   Soneji, Samir ^dw,dx   Stathopoulou, Vasiliki ^dy   Stroumpoulis, Konstantinos ^dz   Sufiyan, Muawiyyah Babale ^cv   Sykes, Bryan L ^ea   Tabarés Seisdedos, Rafael ^az   Tadese, Fentaw ^eb   Tedla, Bemnet Amare ^ec   Tessema, Gizachew Assefa ^ai,ec   Thakur, J S ^ed   Tran, Bach Xuan ^ee   Ukwaja, Kingsley Nnanna ^ef   Chudi Uzochukwu, Benjamin S ^eg   Vlassov, Vasiliy Victorovich ^eh   Weiderpass, Elisabete ^ei,ej,ek,el   Wubshet Terefe, Mamo ^em   Yebyo, Henock Gebremedhin ^af   Yimam, Hassen Hamid ^an   Yonemoto, Naohiro ^en   Younis, Mustafa Z ^eo   Yu, Chuanhua ^ep   Zaidi, Zoubida ^eq   Zaki, Maysaa El Sayed ^ck   Zenebe, Zerihun Menlkalew ^af   Murray, Christopher J L ^b   Naghavi, Mohsen ^b   more..

^a UNIVERSITY OF WASHINGTON   (United States)

^b UNIVERSITY OF WASHINGTON   (United States)

^c UNIVERSITY OF GOTHENBURG   (Sweden)

^d AGA KHAN UNIVERSITY   (Pakistan)

^e GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

^f UNIVERSITY OF OCCUPATIONAL AND ENVIRONMENTAL HEALTH   (Japan)

^g PUBLIC HEALTH FOUNDATION OF INDIA   (India)

^h International Foundation for Dermatology   (United Kingdom)

ⁱ ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^j UNIVERSITY OF HEIDELBERG   (Germany)

^k BALL STATE UNIVERSITY   (United States)

^l NATIONAL CANCER INSTITUTE   (United States)

^m LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

ⁿ CHINESE CENTER FOR DISEASE CONTROL AND PREVENTION   (China)

^o UNIVERSITY OF MELBOURNE   (Australia)

^p UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^q HARVARD UNIVERSITY   (United States)

^r MARSHALL UNIVERSITY SCHOOL OF MEDICINE   (United States)

^s UNIVERSITY OF KWAZULU NATAL   (South Africa)

^t Fred Hutchinson Cancer Research Center   (United States)

^u UNIVERSITY OF TOKYO   (Japan)

^v QUEENSLAND UNIVERSITY OF TECHNOLOGY   (Australia)

^w NORWEGIAN INSTITUTE OF PUBLIC HEALTH   (Norway)

^x FEDERAL INSTITUTE FOR POPULATION RESEARCH   (Germany)

^y LEIBNIZ INSTITUTE FOR PREVENTION RESEARCH AND EPIDEMIOLOGY BIPS   (Germany)

^z CAIRO UNIVERSITY   (Egypt)

^aa JIMMA UNIVERSITY   (Ethiopia)

^ab UNIVERSITY OF SHEFFIELD   (United Kingdom)

^ac QUEENSLAND HEALTH   (Australia)

^ad KING SAUD UNIVERSITY   (Saudi Arabia)

^ae DEBRE MARKOS UNIVERSITY   (Ethiopia)

^af MEKELLE UNIVERSITY   (Ethiopia)

^ag UNIVERSITY OF OXFORD   (United Kingdom)

^ah MINISTRY OF HEALTH   (Saudi Arabia)

^ai UNIVERSITY OF ADELAIDE   (Australia)

^aj BAHIR DAR UNIVERSITY   (Ethiopia)

^ak KOMFO ANOKYE TEACHING HOSPITAL   (Ghana)

^al UNIVERSITY OF MANITOBA   (Canada)

^am QOM UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^an MIZAN TEPI UNIVERSITY   (Ethiopia)

^ao Department of Cardiac Anesthesia   (India)

^ap UNIVERSITY OF ADEN   (Yemen)

^aq UNIVERSITY OF BELGRADE   (Serbia)

^ar JAZAN UNIVERSITY   (Saudi Arabia)

^as UNIVERSITY OF SÃO PAULO   (Brazil)

^at DEBRE BERHAN UNIVERSITY   (Ethiopia)

^au KING'S COLLEGE LONDON   (United Kingdom)

^av UNIVERSITY OF GLOBAL HEALTH EQUITY   (Rwanda)

^aw HARVARD MEDICAL SCHOOL   (United States)

^ax INSTITUTO NACIONAL DE SALUD PÚBLICA   (Mexico)

^ay INSTITUTO NACIONAL DE SALUD   (Colombia)

^az UNIVERSITY OF VALENCIA   (Spain)

^ba OTTAWA HOSPITAL RESEARCH INSTITUTE   (Canada)

^bb GOLD COAST HOSPITAL AND HEALTH SERVICE   (Australia)

^bc NATIONAL CENTER FOR CHILD HEALTH AND DEVELOPMENT   (Japan)

^bd MINISTRY OF HEALTH   (Iraq)

^be Seoul National University Hospital   (South Korea)

^bf PETER DOHERTY INSTITUTE FOR INFECTION AND IMMUNITY   (Australia)

^bg WOLAITA SODO UNIVERSITY   (Ethiopia)

^bh UNIVERSITY OF PORTO   (Portugal)

^bi UNIVERSITY OF PERADENIYA   (Sri Lanka)

^bj UNIVERSITY OF SYDNEY   (Australia)

^bk NATIONAL CENTER FOR CHRONIC DISEASE PREVENTION AND HEALTH PROMOTION   (United States)

^bl ARBA MINCH UNIVERSITY   (Ethiopia)

^bm HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^bn MASSACHUSETTS GENERAL HOSPITAL   (United States)

^bo TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^bp CBQF CENTRO DE BIOTECNOLOGIA E QUÍMICA FINA LABORATÓRIO ASSOCIADO   (Portugal)

^bq BIELEFELD UNIVERSITY   (Germany)

^br Federated States of Micronesia   (Federated States of Micronesia)

^bs ADDIS ABABA UNIVERSITY   (Ethiopia)

^bt Nevada Division of Public and Behavioral Health   (United States)

^bu YOKOHAMA CITY UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^bv BIRZEIT UNIVERSITY   (Palestine)

^bw INTERNATIONAL AGENCY FOR RESEARCH ON CANCER   (France)

^bx AMERICAN CANCER SOCIETY   (United States)

^by UNIVERSITY OF KRAGUJEVAC   (Serbia)

^bz UNIVERSITY OF COLORADO   (United States)

^ca NEWCASTLE UNIVERSITY   (United Kingdom)

^cb Yonsei University   (South Korea)

^cc TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^cd JORDAN UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Jordan)

^ce Seoul National University   (South Korea)

^cf Seoul National University College of Medicine   (South Korea)

^cg NORTHEASTERN UNIVERSITY   (United States)

^ch UNIVERSITY OF SYDNEY   (Australia)

^ci UNIVERSITY OF HAIFA   (Israel)

^cj ROYAL LIVERPOOL AND BROADGREEN UNIVERSITY HOSPITALS NHS TRUST   (United Kingdom)

^ck MANSOURA UNIVERSITY   (Egypt)

^cl SHIRAZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^cm FEDERAL UNIVERSITY OF MINAS GERAIS   (Brazil)

^cn ARSI UNIVERSITY   (Ethiopia)

^co UNITED NATIONS POPULATION FUND   (United States)

^cp HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

^cq PACIFIC INSTITUTE FOR RESEARCH AND EVALUATION   (United States)

^cr CURTIN UNIVERSITY   (Australia)

^cs Tishk International University   (Iraq)

^ct SALAHADDIN UNIVERSITY   (Iraq)

^cu BAQIYATALLAH UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^cv AHMADU BELLO UNIVERSITY   (Nigeria)

^cw IRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^cx UNIVERSITY OF ULM   (Germany)

^cy Ministry of Health   (Fiji)

^cz DUY TAN UNIVERSITY   (Viet Nam)

^da CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^db UNIVERSITY OF WESTERN SYDNEY   (Australia)

^dc UNIVERSITY OF ARIZONA   (United States)

^dd JSS MEDICAL COLLEGE   (India)

^de Kosin University   (South Korea)

^df UNIVERSITY OF PORTO   (Portugal)

^dg Section Exposure Assessment and Environmental Health Indicators   (Germany)

^dh ALBORZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^di A T STILL UNIVERSITY   (United States)

^dj Contech School of Public Health ^*  (Pakistan)

^dk RESEARCH AND EVALUATION DIVISION   (Bangladesh)

^dl Department of Epidemiology and Biostatistics   (Pakistan)

^dm STAVANGER UNIVERSITY HOSPITAL   (Norway)

^dn UNIVERSITY OF BERGEN   (Norway)

^do ALL INDIA INSTITUTE OF MEDICAL SCIENCES   (India)

^dp MARSHALL UNIVERSITY   (United States)

^dq TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^dr Stanford University ^*  (Pakistan)

^ds FUDAN UNIVERSITY   (China)

^dt NORTHUMBRIA UNIVERSITY   (United Kingdom)

^du HARAMAYA UNIVERSITY   (Ethiopia)

^dv STANFORD UNIVERSITY   (United States)

^dw DARTMOUTH INSTITUTE FOR HEALTH POLICY AND CLINICAL PRACTICE   (United States)

^dx NORRIS COTTON CANCER CENTER   (United States)

^dy NATIONAL AND KAPODISTRIAN UNIVERSITY OF ATHENS   (Greece)

^dz KAT HOSPITAL   (Greece)

^ea UNIVERSITY OF CALIFORNIA   (United States)

^eb WOLLO UNIVERSITY   (Ethiopia)

^ec UNIVERSITY OF GONDAR   (Ethiopia)

^ed POSTGRADUATE INSTITUTE OF MEDICAL EDUCATION AND RESEARCH   (India)

^ee JOHNS HOPKINS UNIVERSITY   (United States)

^ef FEDERAL TEACHING HOSPITAL   (Nigeria)

^eg UNIVERSITY OF NIGERIA   (Nigeria)

^eh NATIONAL RESEARCH UNIVERSITY HIGHER SCHOOL OF ECONOMICS   (Russian Federation)

^ei CANCER REGISTRY OF NORWAY   (Norway)

^ej KAROLINSKA INSTITUTE   (Sweden)

^ek FOLKHÄLSAN RESEARCH CENTER   (Finland)

^el UNIVERSITY OF TROMSØ   (Norway)

^em ST PAUL S HOSPITAL MILLENNIUM MEDICAL COLLEGE   (Ethiopia)

^en KYOTO UNIVERSITY   (Japan)

^eo JACKSON STATE UNIVERSITY   (United States)

^ep WUHAN UNIVERSITY   (China)

^eq Setif 1 University   (Algeria)

more..

Author keywords

[No Author keywords available]

Indexed keywords

AGE DISTRIBUTION; FEMALE; GLOBAL DISEASE BURDEN; HUMAN; INCIDENCE; MALE; NEOPLASMS; SEX RATIO; TIME FACTOR; TRENDS;

AGE DISTRIBUTION; FEMALE; GLOBAL BURDEN OF DISEASE; HUMANS; INCIDENCE; MALE; NEOPLASMS; SEX DISTRIBUTION; TIME FACTORS;

EID: 85018321414     PISSN: 23742437     EISSN: 23742445     Source Type: Journal    
DOI: 10.1001/jamaoncol.2017.0098     Document Type: Erratum

References (69)

1. GBD 2015 Mortality and Causes of Death Collaborators. Global, regional, and national life expectancy, all-cause mortality, and cause-specific mortality for 249 causes of death, 1980-2015: a systematic analysis for the Global Burden of Disease Study 2015. Lancet. 2016;388(10053):1459-1544.
2. Lowy DR, Collins FS. Aiming high: changing the trajectory for cancer. N Engl J Med. 2016;374(20):1901-1904. doi:10.1056/NEJMp1600894
3. Grady D. A sickened body as cancer weapon. The New York Times. July 30, 2016.
4. Hanahan D. Rethinking the war on cancer. Lancet. 2014;383(9916):558-563. doi:10.1016/S0140-6736(13)62226-6
5. Horton S, Gauvreau CL. Cancer in Low- and Middle-Income Countries: An Economic Overview. In: Gelband H, Jha P, Sankaranarayanan R, Horton S, eds. Cancer: Disease Control Priorities. Vol 3. 3rd ed. Washington, DC: The International Bank for Reconstruction and Development / The World Bank; 2015, http://www.ncbi.nlm.nih.gov/books /NBK343620/. Accessed July 31, 2016.
6. Committee on Improving the Quality of Cancer Care. In: Levit L, Balogh E, Nass S, Ganz PA, eds. Addressing the Challenges of an Aging Population, Board on Health Care Services, Institute of Medicine. Delivering High-Quality Cancer Care: Charting a New Course for a System in Crisis. Washington, DC: National Academies Press; 2013, https://www.nap.edu/catalog/18359. Accessed August 5, 2016.
7. Coleman MP. Cancer survival: global surveillance will stimulate health policy and improve equity. Lancet. 2014;383(9916):564-573. doi:10.1016/S0140-6736(13)62225-4
8. Stringhini S, Sabia S, Shipley M, et al. Association of socioeconomic position with health behaviors and mortality. JAMA. 2010;303(12):1159-1166. doi:10.1001/jama.2010.297
9. Stringhini S, Berkman L, Dugravot A, et al. Socioeconomic status, structural and functional measures of social support, and mortality: The British Whitehall II Cohort Study, 1985-2009. Am J Epidemiol. 2012;175(12):1275-1283. doi:10.1093/aje/kwr461
10. Vineis P, Wild CP. Global cancer patterns: causes and prevention. Lancet. 2014;383(9916): 549-557. doi:10.1016/S0140-6736(13)62224-2
11. United Nations. Sustainable Development Goals. https://sustainabledevelopment.un.org/. Accessed September 1, 2016.
12. GBD 2015 Disease and Injury Incidence and Prevalence Collaborators. Global, regional, and national incidence, prevalence, and years lived with disability for 310 diseases and injuries, 1990-2015: a systematic analysis for the Global Burden of Disease Study 2015. Lancet. 2016;388(10053):1545-1602.
13. Fitzmaurice C, Dicker D, Pain A, et al; Global Burden of Disease Cancer Collaboration. The Global Burden of Cancer 2013. JAMA Oncol. 2015;1(4):505-527. doi:10.1001/jamaoncol.2015.0735
14. Stevens GA, Alkema L, Black RE, et al; GATHER Working Group. Guidelines for Accurate and Transparent Health Estimates Reporting: the GATHER statement. PLoS Med. 2016;13(6):e1002056. doi:10.1371/journal.pmed.1002056
15. Murray CJL, Lopez AD. Measuring the global burden of disease. N Engl J Med. 2013;369(5):448-457. doi:10.1056/NEJMra1201534
16. Lomas A, Leonardi-Bee J, Bath-Hextall F. A systematic review of worldwide incidence of nonmelanoma skin cancer. Br J Dermatol. 2012;166(5):1069-1080. doi:10.1111/j.1365-2133.2012.10830.x
17. Foreman KJ, Lozano R, Lopez AD, Murray CJ. Modeling causes of death: an integrated approach using CODEm. Popul Health Metr. 2012;10(1):1. doi:10.1186/1478-7954-10-1
18. GBD 2013 Mortality and Causes of Death Collaborators. Global, regional, and national age-sex specific all-cause and cause-specific mortality for 240 causes of death, 1990-2013: a systematic analysis for the Global Burden of Disease Study 2013. Lancet. 2015;385(9963):117-171. doi:10.1016/S0140-6736(14)61682-2
19. GBD 2015 DALYs and HALE Collaborators. Global, regional, and national disability-adjusted life-years (DALYs) for 315 diseases and injuries and healthy life expectancy (HALE), 1990-2015: a systematic analysis for the Global Burden of Disease Study 2015. Lancet. 2016;388(10053):1603-1658.
20. Clark H. NCDs: a challenge to sustainable human development. Lancet. 2013;381(9866):510-511. doi:10.1016/S0140-6736(13)60058-6
21. United Nations. 2011 High-level meeting on prevention and control of non-communicable diseases. http://www.un.org/en/ga/ncdmeeting2011/. Accessed October 27, 2016.
22. World Health Organization. Global Action Plan for the prevention and control of NCDs 2013-2020. http://www.who.int/nmh/events/ncd-action-plan/en/. Accessed October 27, 2016
23. Lim S; GBD 2015 SDG Collaborators. Measuring the health-related Sustainable Development Goals in 188 countries: a baseline analysis from the Global Burden of Disease Study 2015. Lancet. 2016;388(10053):1813-1850.
24. Stefan DC. Cancer Care in Africa: an overview of resources. J Glob Oncol. 2015;1(1):30-36. doi:10.1200/JGO.2015.000406
25. Gelband H, Sankaranarayanan R, Gauvreau CL, et al; Disease Control Priorities-3 Cancer Author Group. Costs, affordability, and feasibility of an essential package of cancer control interventions in low-income and middle-income countries: key messages from Disease Control Priorities, 3rd edition. Lancet. 2016;387(10033):2133-2144. doi:10.1016/S0140-6736(15)00755-2
26. Chalkidou K, Marquez P, Dhillon PK, et al. Evidence-informed frameworks for cost-effective cancer care and prevention in low, middle, and high-income countries. Lancet Oncol. 2014;15(3):e119-e131. doi:10.1016/S1470-2045(13)70547-3
27. Ilbawi AM, Anderson BO. Global cancer consortiums: moving from consensus to practice. Ann Surg Oncol. 2015;22(3):719-727. doi:10.1245/s10434-014-4346-6
28. Carlson JW, Lyon E, Walton D, et al. Partners in pathology: a collaborative model to bring pathology to resource poor settings. Am J Surg Pathol. 2010;34(1):118-123. doi:10.1097/PAS.0b013e3181c17fe6
29. Qu C, Chen T, Fan C, et al. Efficacy of neonatal HBV vaccination on liver cancer and other liver diseases over 30-year follow-up of the Qidong hepatitis B intervention study: a cluster randomized controlled trial. PLoS Med. 2014;11(12):e1001774. doi:10.1371/journal.pmed.1001774
30. World Health Organization. Global health sector strategy on viral hepatitis 2016-2021. June 2016. http://www.who.int/hepatitis/strategy2016-2021/ghss-hep/en/. Accessed September 9, 2016.
31. Petrick JL, Braunlin M, Laversanne M, Valery PC, Bray F, McGlynn KA. International trends in liver cancer incidence, overall and by histologic subtype, 1978-2007. Int J Cancer. 2016;139(7):1534-1545. doi:10.1002/ijc.30211
32. Ryerson AB, Eheman CR, Altekruse SF, et al. Annual Report to the Nation on the Status of Cancer, 1975-2012, featuring the increasing incidence of liver cancer. Cancer. 2016;122(9):1312-1337. doi:10.1002/cncr.29936
33. Peto J, Gilham C, Fletcher O, Matthews FE. The cervical cancer epidemic that screening has prevented in the UK. Lancet. 2004;364(9430):249-256. doi:10.1016/S0140-6736(04)16674-9
34. Tsu V, Jerónimo J. Saving the world's women from cervical cancer. N Engl J Med. 2016;374(26):2509-2511. doi:10.1056/NEJMp1604113
35. Arbyn M, Raifu AO, Weiderpass E, Bray F, Anttila A. Trends of cervical cancer mortality in the member states of the European Union. Eur J Cancer. 2009;45(15):2640-2648. doi:10.1016/j.ejca.2009.07.018
36. Action CC. Investing in cervical cancer prevention 2015-2020; meeting report London, November 3 & 4, 2015. http://www.cervicalcanceraction.org/pubs/pubs.php. Accessed August 13, 2016.
37. de Martel C, Forman D, Plummer M. Gastric cancer: epidemiology and risk factors. Gastroenterol Clin North Am. 2013;42(2):219-240. doi:10.1016/j.gtc.2013.01.003
38. Yang P, Zhou Y, Chen B, et al. Overweight, obesity and gastric cancer risk: results from a meta-analysis of cohort studies. Eur J Cancer. 2009;45(16):2867-2873. doi:10.1016/j.ejca.2009.04.019
39. Steffen A, Huerta J-M, Weiderpass E, et al. General and abdominal obesity and risk of esophageal and gastric adenocarcinoma in the European Prospective Investigation into Cancer and Nutrition. Int J Cancer. 2015;137(3):646-657. doi:10.1002/ijc.29432
40. Ford AC, Forman D, Hunt RH, Yuan Y, Moayyedi P. Helicobacter pylori eradication therapy to prevent gastric cancer in healthy asymptomatic infected individuals: systematic review and meta-analysis of randomised controlled trials. BMJ. 2014;348:g3174-g3174. doi:10.1136/bmj.g3174
41. International Agency for Research on Cancer. Helicobacter pylori eradication as a strategy for preventing gastric cancer. http://www.iarc.fr/en/publications/pdfs-online/wrk/wrk8/index.php. Accessed October 27, 2016.
42. Choi KS, Jun JK, Suh M, et al. Effect of endoscopy screening on stage at gastric cancer diagnosis: results of the National Cancer Screening Programme in Korea. Br J Cancer. 2015;112(3):608-612. doi:10.1038/bjc.2014.608
43. Lee K-J, Inoue M, Otani T, Iwasaki M, Sasazuki S, Tsugane S; JPHC Study Group. Gastric cancer screening and subsequent risk of gastric cancer: a large-scale population-based cohort study, with a 13-year follow-up in Japan. Int J Cancer. 2006;118(9):2315-2321. doi:10.1002/ijc.21664
44. Leung WK, Wu MS, Kakugawa Y, et al; Asia Pacific Working Group on Gastric Cancer. Screening for gastric cancer in Asia: current evidence and practice. Lancet Oncol. 2008;9(3):279-287. doi:10.1016/S1470-2045(08)70072-X
45. Miyamoto A, Kuriyama S, Nishino Y, et al. Lower risk of death from gastric cancer among participants of gastric cancer screening in Japan: a population-based cohort study. Prev Med. 2007;44(1):12-19. doi:10.1016/j.ypmed.2006.07.016
46. Mizoue T, Yoshimura T, Tokui N, et al; Japan Collaborative Cohort Study Group. Prospective study of screening for stomach cancer in Japan. Int J Cancer. 2003;106(1):103-107. doi:10.1002/ijc.11183
47. Plummer M, de Martel C, Vignat J, Ferlay J, Bray F, Franceschi S. Global burden of cancers attributable to infections in 2012: a synthetic analysis. Lancet Glob Health. 2016;4(9):e609-e616. doi:10.1016/S2214-109X(16)30143-7
48. Forouzanfar MH, Murray CJL, Afshin A; GBD 2015 Risk Factors Collaborators. Global, regional, and national comparative risk assessment of 79 behavioural, environmental and occupational, and metabolic risks or clusters of risks, 1990-2015: a systematic analysis for the Global Burden of Disease Study 2015. Lancet. 2016;388(10053):1659-1724.
49. Chan AT, Giovannucci EL. Primary prevention of colorectal cancer. Gastroenterology. 2010;138(6):2029-2043.e10. doi:10.1053/j.gastro.2010.01.057
50. Cao Y, Nishihara R, Wu K, et al. Population-wide impact of long-term use of aspirin and the risk for cancer. JAMA Oncol. 2016;2(6):762-769. doi:10.1001/jamaoncol.2015.6396
51. Clague J, Bernstein L. Physical activity and cancer. Curr Oncol Rep. 2012;14(6):550-558. doi:10.1007/s11912-012-0265-5
52. Wolk A. Potential health hazards of eating red meat. J Intern Med. 2016;(September). doi:10.1111/joim.12543
53. Zauber AG, Winawer SJ, O'Brien MJ, et al. Colonoscopic polypectomy and long-term prevention of colorectal-cancer deaths. N Engl J Med. 2012;366(8):687-696. doi:10.1056/NEJMoa1100370
54. Lin JS, Piper MA, Perdue LA, et al. Screening for colorectal cancer: updated evidence report and systematic review for the US Preventive Services Task Force. JAMA. 2016;315(23):2576-2594. doi:10.1001/jama.2016.3332
55. Siripongpreeda B, Mahidol C, Dusitanond N, et al. High prevalence of advanced colorectal neoplasia in the Thai population: a prospective screening colonoscopy of 1,404 cases. BMC Gastroenterol. 2016;16(1):101. doi:10.1186/s12876-016-0526-0
56. Colditz GA, Bohlke K. Priorities for the primary prevention of breast cancer. CA Cancer J Clin. 2014;64(3):186-194. doi:10.3322/caac.21225
57. Anderson BO, Lipscomb J, Murillo RH, Thomas DB. Breast Cancer. In: Gelband H, Jha P, Sankaranarayanan R, Horton S, eds. Cancer: Disease Control Priorities. Vol 3. 3rd ed. Washington, DC: The International Bank for Reconstruction and Development / The World Bank; 2015, http://www.ncbi.nlm.nih.gov/books/NBK343636/. Accessed September 14, 2016.
58. Anderson BO, Cazap E, El Saghir NS, et al. Optimisation of breast cancer management in low-resource and middle-resource countries: executive summary of the Breast Health Global Initiative consensus, 2010. Lancet Oncol. 2011;12(4):387-398. doi:10.1016/S1470-2045(11)70031-6
59. Allemani C, Weir HK, Carreira H, et al; CONCORD Working Group. Global surveillance of cancer survival 1995-2009: analysis of individual data for 25,676,887 patients from 279 population-based registries in 67 countries (CONCORD-2). Lancet. 2015;385(9972):977-1010.
60. Chang ET, Adami H-O. The enigmatic epidemiology of nasopharyngeal carcinoma. Cancer Epidemiol Biomarkers Prev. 2006;15(10):1765-1777. doi:10.1158/1055-9965.EPI-06-0353
61. Gandini S, Sera F, Cattaruzza MS, et al. Meta-analysis of risk factors for cutaneous melanoma: III, family history, actinic damage and phenotypic factors. Eur J Cancer. 2005;41(14):2040-2059. doi:10.1016/j.ejca.2005.03.034
62. Arnold M, Soerjomataram I, Ferlay J, Forman D. Global incidence of oesophageal cancer by histological subtype in 2012. Gut. 2015;64(3):381-387.
63. Loomis D, Guyton KZ, Grosse Y, et al; International Agency for Research on Cancer Monograph Working Group. Carcinogenicity of drinking coffee, mate, and very hot beverages. Lancet Oncol. 2016;17(7):877-878. doi:10.1016/S1470-2045(16)30239-X
64. Holmes RS, Vaughan TL. Epidemiology and pathogenesis of esophageal cancer. Semin Radiat Oncol. 2007;17(1):2-9. doi:10.1016/j.semradonc.2006.09.003
65. Pera M, Manterola C, Vidal O, Grande L. Epidemiology of esophageal adenocarcinoma. J Surg Oncol. 2005;92(3):151-159. doi:10.1002/jso.20357
66. Mikkelsen L, Phillips DE, AbouZahr C, et al. A global assessment of civil registration and vital statistics systems: monitoring data quality and progress. Lancet. 2015;386(10001):1395-1406. doi:10.1016/S0140-6736(15)60171-4
67. Flaxman AD, Vahdatpour A, James SL, Birnbaum JK, Murray CJ; Population Health Metrics Research Consortium (PHMRC). Direct estimation of cause-specific mortality fractions from verbal autopsies: multisite validation study using clinical diagnostic gold standards. Popul Health Metr. 2011;9(1):35. doi:10.1186/1478-7954-9-35
68. Bray F. The evolving scale and profile of cancer worldwide: much ado about everything. Cancer Epidemiol Biomarkers Prev. 2016;25(1):3-5. doi:10.1158/1055-9965.EPI-15-1109
69. Ahern RM, Lozano R, Naghavi M, Foreman K, Gakidou E, Murray CJ. Improving the public health utility of global cardiovascular mortality data: the rise of ischemic heart disease. Popul Health Metr. 2011;9(1):8. doi:10.1186/1478-7954-9-8